Journal of Pediatric Health Care
Volume 20, Issue 6 , Pages 426-429 , November 2006

Vaccine Shortages: Implications for Pediatric Nurse Practitioners

  • Deborah Callender, MS, CPNP

      Affiliations

    • Corresponding Author InformationReprint requests: Deborah Callender, MS, CPNP, 8921 Applecross Lane, Springfield, VA 22153.

References 

  1. Albert B. Sabin Vaccine Institute. (2004). Feasible solutions to global vaccine shortages: proceedings of the Albert B. Sabin Vaccine Institute tenth annual vaccine colloquium. Sabin Vaccine Report, VI, 3.
  2. Centers for Disease Control and Prevention. Notice to readers: Resumption of routine schedule for tetanus and diphtheria toxoids. MMWR Morbidity and Mortality Weekly Report. 2002;51:529–530
  3. Centers for Disease Control and Prevention. Notice to readers: Pneumococcal conjugate vaccine shortage resolved. MMWR Morbidity and Mortality Weekly Report. 2003;52:446–447
  4. Centers for Disease Control and Prevention. Notice to readers: Pneumococcal conjugate vaccine shortage resolved. MMWR Morbidity and Mortality Weekly Report. 2004;53:851–852
  5. Centers for Disease Control and Prevention. Estimated influenza coverage among adults and children-United States, September 1-November 30, 2004. MMWR Morbidity and Mortality Weekly Report. 2004;53:1147–1153
  6. Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. 9th ed.. Washington, DC: Public Health Foundation; 2006;
  7. Centers for Disease Control and Prevention. Notice to readers: Limited supply of meningococcal conjugate vaccine, recommendation to defer vaccination of persons aged 11-12 years. MMWR Morbidity and Mortality Weekly Report. 2006;55:1
  8. Congeni B. Vaccine shortages: Eliminate possibility for excess capacity in stockpiles. Pediatric Annals. 2004;33:577–583
  9. DesRoches C, Blendon R, Benson J. Americans’ responses to the 2004 influenza vaccine shortage. Health Affairs. 2005;24:822–831
  10. Inglehart N. The vaccine enterprise [Special issue]. Health Affairs. 2005;24:594–769
  11. Institute of Medicine. Financing vaccines in the 21st century: Assuring access and availability. Washington, D.C: The National Academies Press; 2004;
  12. Kairys S, Gubernick R, Millican A, Adams W. Using a registry to improve immunization delivery. Pediatric Annals. 2006;35:500–506
  13. Klein J, Myers M. Vaccine shortages: Why they occur and what needs to be done to strengthen vaccine supply. Pediatrics. 2006;117:2269–2275
  14. Offit P. Why are pharmaceutical companies gradually abandoning vaccines?. Health Affairs. 2005;24:622–630
  15. Rusk J. CDC recommends MCV4 deferral. Pediatric Infectious Diseases in Children. 2006;19(6):28
  16. Santoli J. Strengthening the supply of routinely recommended vaccines in the United States: Recommendations from the National Vaccine Advisory Committee. JAMA. 2003;290:3122–3128
  17. United States General Accounting Office. (2002). Childhood vaccines: Ensuring an adequate supply poses continuing challenges (GAO-02-987). Author.

PII: S0891-5245(06)00482-2

doi: 10.1016/j.pedhc.2006.08.007

Journal of Pediatric Health Care
Volume 20, Issue 6 , Pages 426-429 , November 2006